Dataset Information

Identical Tumor Antigen Peptides by Canine and Human MHC Class I

ABSTRACT: Arobust immunopeptidomics workflow was developed to purify DLA_bound peptides from canine tumors and DLA-transduced monoallelic cell lines. This method was used to characterize the peptide repertoire and peptide binding motif of multiple DLA class I molecules

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human) Canis Familiaris (dog) (canis Lupus Familiaris)

TISSUE(S): Permanent Cell Line Cell, Melanocyte, Melanoma Cell, Cell Culture, Mesenchymal Cell, Bone, Anal Sac, Apocrine Gland

DISEASE(S): Osteosarcoma,Melanoma,Anal Gland Adenocarcinoma

SUBMITTER: Hooman Yari

LAB HEAD: William Hildebrand

PROVIDER: PXD074485 | Pride | 2026-04-22

REPOSITORIES: Pride

ACCESS DATA

Dataset's files

Source:

			Action	DRS
	20240913-HCT116-DLA8800302-091124.zip	Other
	20241013-HCT116-DLA8801201-BB76.zip	Other
	20241015-HCT116-DLA8850101-BB76.zip	Other
	20250123-BogeyTumor-BB76-010825.zip	Other
	20250310-LolaTumor-BB76-022725.zip	Other

Items per page:

1 - 5 of 11

Similar Datasets

Project description:In this study, we present the first comparison of global transcriptional changes taking place in canine lymphoma and human diffuse large B-cell lymphoma (DLBCL), with particular reference to the nuclear factor-kappaB (NF-?B) pathway. Microarray data generated from lymph nodes diagnosed with canine DLBCL and healthy lymph nodes were used for differential expression analysis, co-expression analysis and pathway analysis, and compared with analysis of publicly available microarray data from human healthy and DLBCL lymph nodes. The comparisons between species at gene level were performed by mapping the probesets in canine microarrays to orthologous genes in humans and vice versa. A considerable number of differentially expressed genes between canine lymphoma and healthy lymph node samples were also found differentially expressed between human DLBCL and healthy lymph node samples. Principal component analysis (PCA) using a literature derived 120 NF-?B target gene set mapped to 199 orthologous canine array probesets and 259 human array probesets clearly separated the healthy and cancer samples in both canine and human datasets. The analysis demonstrated that for both human and canine DLBCL there is activation of the NF-?B/p65 canonical pathway rather than the alternative pathway. This has therapeutic implications for the use of specific pathway inhibitors for the treatment of DLBCL for both species and also indicates that naturally occurring canine lymphoma could be used as a model to study therapeutic strategies for human lymphoma. The model was further validated by the identification of molecular signatures that could sub-classify canine DLBCL into activated B-cell-like (ABC) or germinal centre B-cell-like (GCB) types equivalent to human subtypes. Canine DLBCL patients were recruited via the clinical oncology service of the University of Edinburgh Royal (Dick) School of Veterinary Studies (DJA), and the University of Wisconsin-Madison School of Veterinary Medicine (DMV). Lymph node biopsy samples were taken, as part of normal diagnostic procedures, from dogs newly diagnosed with lymphoma (naïve) and samples from dogs that had relapsed following standard of care CHOP chemotherapy. Only dogs with confirmed DLBCL after pathological grading were used in this study. This included standard histopathological grading by two independent pathologists and CD3/PAX5 marker analysis. Normal lymph node samples were obtained from canines that were euthanized for non-lymphoma conditions. Microarray data were generated from 35 canine samples (25 DLBCL and 10 healthy) in total. However, data from 2 canine DLBCL samples did not meet our required quality and were removed from further analysis. Only data from 33 (23 DLBCL and 10 healthy) samples were used for analysis. The generated data were used for differential expression analysis, co-expression analysis and pathway analysis, and compared with analysis of publicly available microarray data (GSE12195) from human healthy and DLBCL lymph nodes. The comparisons between species at gene level were performed by mapping the probesets in canine microarrays to orthologous genes in humans and vice versa.

Dataset Information

Identical Tumor Antigen Peptides by Canine and Human MHC Class I

Dataset's files

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets